MATINAS BIOPHARMA HOLDINGS, INC. Gain (Loss) on Investments
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Gain (Loss) on Investments of $484.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2025-04-15
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for the quarter ending 2022-12-31 was $1.76M.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for the quarter ending 2022-09-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for the quarter ending 2022-06-30 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for the quarter ending 2022-03-31 was $1.73M, a 30.53% increase year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for fiscal 2023 was $484.00K, a 86.14% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for fiscal 2022 was $3.49M, a 162.88% increase from fiscal 2021.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for fiscal 2021 was $1.33M, a 23.73% increase from fiscal 2020.
- MATINAS BIOPHARMA HOLDINGS, INC. gain (loss) on investments for fiscal 2020 was $1.07M, a 6.57% increase from fiscal 2019.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 3 month as first filed | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $484.00K 10-K · filed 2025-04-15 | |||||||
| 2022-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.76M derived: sum of 2 quarters · filed 2024-03-27 | $1.76M derived: sum of 3 quarters · filed 2024-03-27 | $3.49M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $1.73M 10-Q · filed 2023-11-08 | $1.73M 10-Q · filed 2022-11-02 | $1.73M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.73M 10-Q · filed 2023-08-09 | $1.73M 10-Q · filed 2022-08-11 | $1.73M derived: sum of 3 quarters · filed 2023-08-09 | $1.73M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $1.73M 10-Q · filed 2023-05-10 | $1.73M 10-Q · filed 2022-05-12 | $1.73M derived: sum of 2 quarters · filed 2023-05-10 | $1.73M derived: sum of 3 quarters · filed 2023-05-10 | $1.73M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$470.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$470.00 derived: sum of 2 quarters · filed 2023-03-15 | -$470.00 derived: sum of 3 quarters · filed 2023-03-15 | $1.33M 10-K · filed 2023-03-15 | $1.33M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $0.00 derived: sum of 2 quarters · filed 2022-11-02 | $1.33M 10-Q · filed 2022-11-02 | $1.33M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.33M 10-Q · filed 2022-08-11 | $1.33M derived: sum of 3 quarters · filed 2022-08-11 | $1.33M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $1.33M 10-Q · filed 2022-05-12 | $1.33M derived: sum of 2 quarters · filed 2022-05-12 | $1.33M derived: sum of 3 quarters · filed 2022-05-12 | $1.33M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $1.07M 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $1.07M 10-Q · filed 2021-11-08 | $1.07M derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.07M 10-Q · filed 2021-08-10 | $1.07M derived: sum of 3 quarters · filed 2021-08-10 | $1.07M derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | $1.07M 10-Q · filed 2021-05-10 | $1.07M derived: sum of 2 quarters · filed 2021-05-10 | $1.07M derived: sum of 3 quarters · filed 2021-05-10 | $2.08M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | $1.01M derived: sum of 3 quarters · filed 2021-03-29 | $1.01M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.01M derived: sum of 2 quarters · filed 2020-11-06 | $1.01M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $1.01M 10-Q · filed 2020-08-10 | $1.01M 10-Q · filed 2020-08-10 | ||||||
| 2017-12-31 | $636.93K 10-K · filed 2019-04-01 | |||||||
| 2016-12-31 | $674.90K 10-K · filed 2018-03-16 | |||||||
| 2015-12-31 | $756.47K 10-K · filed 2018-03-16 | |||||||
| 2014-12-31 | $269.13K 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |